SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

CASI Pharmaceuticals Q1 EPS $(0.090), Same YoY

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.090) per share. This is unchanged from the same period last year.

Benzinga · 05/11/2020 11:12

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.090) per share. This is unchanged from the same period last year.